Pharmacists are in the ideal position to help monitor their patients with diabetes. It's essential to consider GLP therapy to aid in achieving the desired composite outcome of adequate glycemic control, without undo risk of hypoglycemia and weight gain. Patients with ASCVD should be offered proven CV protective GLP therapy, regardless of A1c. Pharmacists can and SHOULD take a lead role in ensuring our patients get the most appropriate diabetes regimen for their individual needs.